Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

OBJECTIVE: To study the effect of exenatide on body composition and circulating cardiovascular risk biomarkers. RESEARCH DESIGN AND METHODS: Metformin-treated patients with type 2 diabetes (N = 69) were randomized to exenatide or insulin glargine and treated for 1 year. Body composition was evaluate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2010
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2909051/
https://ncbi.nlm.nih.gov/pubmed/20424219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-2361
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars